MENLO PARK, Calif. , July 24, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Second Quarter 2020 Financial Results on Monday, August 3, 2020 , at 4:30pm Eastern Time .

Dr. Hunkapiller to retire by the end of 2020 Susan K. Barnes , CFO to retire in August 2020 MENLO PARK, Calif. , June 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today

MENLO PARK, Calif. , June 08, 2020 (GLOBE NEWSWIRE) -- The Board of Directors of Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”) has announced that it is rescheduling the date of the Company’s 2020 Annual Meeting of Stockholders (the “Annual Meeting”) previously scheduled for

MENLO PARK, Calif. , May 06, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2020 . As previously announced, in January 2020 , we and Illumina mutually agreed to terminate the Agreement and Plan

MENLO PARK, Calif. , April 27, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its First Quarter 2020 Financial Results on Wednesday, May 6, 2020 , at 4:30pm Eastern Time .

Deployment expands access to PacBio’s highly accurate long reads on the African continent for a variety of applications, from ethnic-specific reference genomes to COVID-19 research MENLO PARK, Calif. and PRETORIA, South Africa , April 20, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California,

LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2 and the related immune response to COVID-19 MENLO PARK, Calif.

MENLO PARK, Calif. , March 18, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury verdict in the U.S. District Court for the District of Delaware was not

MENLO PARK, Calif. , March 05, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that industry veteran Christian Henry has been appointed to serve as Chairman of

Company will sponsor sequencing and assembly at UC Davis to produce reference-grade genomes for several ecologically important organisms in the state of California MENLO PARK, Calif. and DAVIS, Calif. , Feb. 25, 2020 (GLOBE NEWSWIRE) -- The Earth BioGenome Project (EBP) and Pacific Biosciences of